Torrent Pharma UK Ltd

What Torrent Pharma UK Ltd does

Torrent Pharma UK Ltd ('TP-UK') is a private, wholly-owned UK subsidiary of the Indian-headquartered generic pharmaceutical manufacturer Torrent Pharmaceuticals Limited. Founded in 2010 and registered in the UK as Torrent Pharma (UK) Limited (Company Registration No: 7249393), the company operates from a single office in Crawley, West Sussex, and functions as the commercialization and distribution arm for the parent's generic prescription medicines within the United Kingdom. TP-UK's core activity is the sale and distribution of generic pharmaceutical products into three channels: retail pharmacy, wholesale distributors, and hospital customers (including NHS and private hospital trusts). Its product portfolio draws on Torrent Pharmaceuticals Limited's global pipeline — anchored in cardiovascular (CV) and central nervous system (CNS) franchises and extending into gastro-intestinal, diabetology, anti-infective, pain management, gynecology, pediatric, oncology, and rheumatology therapeutic areas.

The company's commercial model is sales-led: it fields dedicated UK teams for sales and customer services, commercial operations, regulatory affairs, quality assurance, and business development. Revenue is generated through one-time product sales of generic prescription medicines, with pricing subject to UK/NHS regulatory frameworks and not publicly disclosed. TP-UK relies on the parent group for molecule development and supply, with stated intent to grow the UK portfolio 'through group development of key pharmaceutical molecules and key partner arrangements.' Pharmacovigilance and adverse-event reporting are outsourced to APCER Life Sciences. Marketing is minimal — primarily a corporate website and LinkedIn presence — consistent with a B2B pharmacy/wholesaler/hospital sales motion rather than direct-to-consumer.

TP-UK is small (11–50 employees) but embedded in a globally significant parent. Torrent Pharmaceuticals Limited operates 8 manufacturing plants, employs 900+ scientists, holds 2,000+ product registrations, and is present in 40 countries — capabilities that flow downstream to TP-UK as a regulatory and supply moat in the UK. TP-UK itself does not disclose revenue, has no independent funding rounds, and is privately held. Its strategic posture is one of selective, channel-diversified expansion within the UK, with recent movement into oncology and rheumatology therapeutic segments and an active recruitment footprint signaling continued build-out.

Name

Torrent Pharma UK Ltd

Legal name

Torrent Pharma (UK) Limited

Website

https://torrentpharma.co.uk

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Torrent Pharma UK Ltd is a wholly-owned UK subsidiary of Torrent Pharmaceuticals Limited that distributes and commercializes generic prescription medicines across cardiovascular, CNS, and other therapeutic areas via retail pharmacy, wholesale, and hospital channels in the UK.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Generic pharmaceutical distribution
• Prescription medicine supply
• Cardiovascular therapeutics
• Hospital pharmacy supply
• NHS generics supply

Headquarters

HQ city

Crawley

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Generic Pharmaceutical Medicines Sales: Torrent Pharma UK Ltd distributes generic pharmaceutical medicines to retail pharmacy, wholesale and hospital sectors. Revenue is generated through the sale of high-quality prescriptive generic medicines at affordable prices, with focus on cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective, pain management, gynecology, pediatric, oncology, and rheumatology therapeutic areas.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Torrent Pharma UK Ltd distributes and commercialises a portfolio of generic prescription medicines across ten therapeutic areas — cardiovascular, central nervous system, gastrointestinal, diabetology, anti-infective, pain management, gynaecology, paediatric, oncology and rheumatology. The products are supplied into the UK retail pharmacy, wholesale and hospital (NHS and private) channels under MHRA and EU FMD regulatory oversight.

Product overview

Torrent Pharma (UK) Ltd is a wholly owned subsidiary of Torrent Pharmaceuticals Limited, specialising in the manufacture and distribution of generic pharmaceutical medicines. The company operates across retail pharmacy, wholesale, and hospital sectors in the UK. Its product portfolio spans multiple therapeutic areas with particular focus on cardiovascular (CV) and central nervous system (CNS) treatments, while also maintaining presence in gastro-intestinal, diabetology, anti-infective, pain management, gynecology, pediatric, oncology, and rheumatology segments. The company positions itself on providing high quality prescriptive medicines at affordable prices.

Differentiator

Problem solved

Functional benefit

Products and services

• TP-UK Generic Prescription Medicines Portfolio A multi-therapy-area generic prescription medicine portfolio covering cardiovascular, central nervous system, gastrointestinal, diabetology, anti-infective, pain management, gynaecology, paediatric, oncology and rheumatology categories, supplied to UK retail pharmacy, wholesale and hospital (NHS and private) channels.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• APCER Life SciencesminorOthersAPCER Life Sciences serves as Torrent Pharma UK Ltd's pharmacovigilance agent for adverse event reporting, medical information requests, and product quality complaints. Healthcare professionals and patients can contact APCER directly for adverse event reporting and medical information. Information submitted to APCER is governed by their privacy policy, not TPUK's.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lupin Pharmaceuticals UK: UK presence of Indian-headquartered Lupin, another vertically integrated generic pharmaceutical major. Comparable parent structure, broad therapeutic portfolio, and similar go-to-market into NHS and retail pharmacy channels.
• Accord Healthcare UK: UK generics subsidiary of Intas Pharmaceuticals with broad generic portfolio across cardiovascular, CNS, oncology, and other therapeutic areas. Closely mirrors Torrent Pharma UK's model as an India-headquartered parent's UK distribution vehicle.
• Sandoz UK: UK generics arm of Novartis and one of the two largest generic pharmaceutical suppliers globally. Closely comparable business model: broad portfolio of off-patent prescription medicines sold into retail pharmacy, wholesale, and hospital channels in the UK.
• Zentiva UK: European generics specialist operating in the UK with broad prescription generic portfolio. Comparable in focus on affordable generic medicines across cardiovascular and CNS, with similar mid-tier UK market positioning.
• Glenmark Pharmaceuticals UK: UK arm of Indian generic major Glenmark. Similar India-parent distribution model, broad generic portfolio across respiratory, dermatology, and cardiovascular — overlapping with Torrent Pharma UK's therapeutic focus areas.
• Aurobindo Pharma UK: UK subsidiary of Aurobindo Pharma, an Indian generic major. Highly comparable: India-based parent with global manufacturing footprint distributing generic prescription medicines into UK retail, wholesale, and hospital channels.

Emerging players

• Ennogen Healthcare: UK-focused mid-sized generic pharmaceutical supplier distributing into NHS, retail pharmacy, and hospital channels. Comparable in size and channel mix to Torrent Pharma UK as a sub-incumbent UK generics challenger.

Broad incumbents

• Sun Pharma UK: UK operations of Sun Pharmaceutical Industries, one of the largest Indian generic manufacturers globally (formed in part via Ranbaxy acquisition). Comparable parent scale and broad generic portfolio including CNS, cardiovascular, and other therapeutic segments.
• Teva UK: UK arm of Teva Pharmaceutical Industries, the world's largest generic manufacturer. Directly comparable as a multi-channel generic prescription medicine distributor serving NHS, retail pharmacy, and hospital channels across overlapping therapeutic areas.
• Viatris UK (formerly Mylan): UK operations of Viatris, a global off-patent medicines specialist. Directly comparable in scale, multi-channel distribution, and broad therapeutic coverage including cardiovascular and CNS — key focus areas for Torrent Pharma UK.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/torrent-pharma-uk-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Torrent Pharma UK Ltd